Beauty Health (NASDAQ:SKIN – Get Rating)‘s stock had its “buy” rating restated by stock analysts at Benchmark in a research note issued on Tuesday, Benzinga reports. They currently have a $23.00 price objective on the stock. Benchmark’s price target suggests a potential upside of 95.08% from the company’s previous close.
Several other equities research analysts also recently issued reports on the company. DA Davidson upped their price target on Beauty Health from $32.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, March 1st. Cowen decreased their price target on Beauty Health from $20.00 to $15.00 and set an “outperform” rating for the company in a report on Thursday, February 16th. The Goldman Sachs Group decreased their price target on Beauty Health from $22.00 to $19.00 and set a “buy” rating for the company in a report on Wednesday, November 23rd. Finally, Piper Sandler cut their price objective on Beauty Health from $16.00 to $15.00 in a research report on Friday, December 16th. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, Beauty Health presently has a consensus rating of “Moderate Buy” and an average target price of $19.75.
Beauty Health Trading Up 2.4 %
NASDAQ SKIN opened at $11.79 on Tuesday. The business has a 50 day moving average price of $11.56 and a 200-day moving average price of $11.17. Beauty Health has a 52 week low of $8.25 and a 52 week high of $19.38. The company has a market cap of $1.56 billion, a price-to-earnings ratio of -65.50 and a beta of 1.16. The company has a quick ratio of 9.20, a current ratio of 10.79 and a debt-to-equity ratio of 4.28.
Institutional Inflows and Outflows
Beauty Health Company Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
- Get a free copy of the StockNews.com research report on Beauty Health (SKIN)
- Meta Platforms: Efficiency Gains Momentum, Stock Accelerates
- Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.